Donoghue Forlines’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-25,531
Closed -$764K 243
2023
Q1
$764K Buy
+25,531
New +$841K 0.28% 104
2022
Q2
Sell
-39,099
Closed -$1.23M 264
2022
Q1
$1.23M Sell
39,099
-16,002
-29% -$501K 0.27% 96
2021
Q4
$1.85M Buy
55,101
+20,424
+59% +$636K 0.31% 68
2021
Q3
$1.01M Sell
34,677
-48,397
-58% -$1.57M 0.2% 131
2021
Q2
$2.89M Sell
83,074
-38,110
-31% -$1.26M 0.54% 40
2021
Q1
$3.38M Buy
+121,184
New +$3.22M 0.66% 27
2020
Q1
Sell
-25,293
Closed -$458K 75
2019
Q4
$458K Sell
25,293
-276,044
-92% -$4.58M 0.07% 150
2019
Q3
$4.5M Buy
301,337
+5,236
+2% +$85.2K 0.64% 29
2019
Q2
$7.11M Buy
+296,101
New +$8.73M 0.83% 19

Other funds holding CC

Donoghue Forlines's CC Position: Q2 2023 in Review

Donoghue Forlines sold out of Chemours (CC) in Q2 2023, closing a stake of 25,531 shares — an estimated $764K sold.

Donoghue Forlines first reported a position in CC in Q2 2019 and held it in 9 quarters. The position peaked at $7.11M in Q2 2019. 476 funds tracked by Wall St. Rank hold CC as of Q2 2023.

  • Donoghue Forlines reported no remaining Chemours position as of Q2 2023 after selling out during the quarter.
  • Donoghue Forlines sold 25,531 Chemours shares in Q2 2023, an estimated $764K.
  • Donoghue Forlines first reported a position in Chemours in Q2 2019 and held it in 9 quarters.
  • Donoghue Forlines's Chemours position peaked at $7.11M in Q2 2019.
  • 476 funds tracked by Wall St. Rank held Chemours as of Q2 2023.

Based on Donoghue Forlines's 13F filing for Q2 2023, filed 7 Aug 2023.